Related Experiment Videos
[Luteinizing hormone (LH) in hypergonadotropic hypogonadism].
Jerzy Jakowicki1, Lechosław Putowski, Artur Jakimiuk
1Kliniki Ginekologii Operacyjnej II Katedry Połoznictwa i Chorób Kobiecych Akademii Medycznej w Lublinie.
Ginekologia Polska
|April 29, 2003
Summary
Serum luteinizing hormone (LH) levels vary significantly in hypergonadotropic hypogonadism. Follicle-stimulating hormone (FSH) is a more reliable indicator for diagnosing this reproductive endocrine disorder.
Area of Science:
- Reproductive Endocrinology
- Clinical Diagnostics
Background:
- Hypergonadotropic hypogonadism presents with elevated gonadotropins (FSH and LH) and low sex steroids.
- Accurate diagnosis is crucial for reproductive health management.
Purpose of the Study:
- To analyze serum LH concentrations in patients with hypergonadotropic hypogonadism.
- To compare LH levels across different etiological subgroups.
- To determine the most reliable hormonal marker for diagnosis.
Main Methods:
- Serum LH and FSH levels were measured in 47 reproductive-aged patients.
- Patients were categorized into groups: 46XY, 45X0 (Turner syndrome), premature ovarian failure, WHO III, and iatrogenic causes.
- Diagnostic methods included clinical assessment, hormonal assays, karyotyping, imaging, and biopsy.
Main Results:
- Mean serum FSH levels were similar across all groups.
- Serum LH was lowest in the 45X0 group and highest in the 46XY and surgically treated groups.
- The LH/FSH ratio was near normal in 46XY and surgically treated groups.
- LH levels showed significant heterogeneity, being lower in ovarian disorders and gonadal dysgenesis.
Conclusions:
- Serum FSH levels are a more consistent indicator for diagnosing hypergonadotropic hypogonadism than LH.
- LH levels exhibit heterogeneous fluctuations, making them less reliable for primary diagnosis.
- Understanding LH variations is important for differentiating causes of hypogonadism.